Citric acid cross-linking of a hydrogel from Aloe vera ( Aloe barbadensis M.) engenders a pH-responsive, superporous, and smart material for drug delivery

Jaffar Irfan,Arshad Ali,Muhammad Ajaz Hussain,Muhammad Tahir Haseeb,Muhammad Naeem-ul-Hassan,Syed Zajif Hussain
DOI: https://doi.org/10.1039/d4ra00095a
IF: 4.036
2024-01-01
RSC Advances
Abstract:The current research work is based on the evaluation of a citric acid (CA) cross-linked Aloe vera ( Aloe barbadensis M.) leaf hydrogel (CL-ALH) for pH-dependent and sustained drug release application.
chemistry, multidisciplinary
What problem does this paper attempt to address?
The main objective of this paper is to develop a novel material based on Aloe vera (Aloe barbadensis M.) leaf hydrogel, which is crosslinked with citric acid (CA) to achieve pH-responsive and sustained drug release applications in drug delivery systems. Specifically, the research team prepared Aloe leaf hydrogel (ALH) by crosslinking under uniform reaction conditions at different citric acid concentrations (1.25%, 2.5%, 5.0%, and 10.0%). The successful synthesis of crosslinked Aloe leaf hydrogel (CL-ALH) was confirmed using techniques such as Fourier-transform infrared spectroscopy (FTIR) and nuclear magnetic resonance (NMR). Thermal analysis results showed that both the original ALH and the crosslinked CL-ALH exhibited good thermal stability. The study also found significant differences in the swelling behavior of CL-ALH at different pH values, showing higher swelling capacity at pH 7.4 and 6.8, and lower swelling capacity at pH 1.2. Additionally, CL-ALH demonstrated swelling/deswelling characteristics in deionized water (DW) and ethanol, DW and saline, as well as between pH 7.4 and pH 1.2. The paper further describes incorporating CL-ALH as a sustained drug release agent into tablets containing venlafaxine hydrochloride (VFX) to test its sustained release capability. Experimental results indicated that tablets containing CL-ALH could sustain the release of VFX over 8 hours, whereas tablets based on non-crosslinked ALH completed VFX release within 4 hours, proving that CL-ALH effectively prolongs drug release time. Finally, X-ray studies observed the behavior of tablets containing CL-ALH in the gastrointestinal tract of dogs, showing that the tablets could safely pass through the stomach and disintegrate in the small intestine and colon. This indicates that CL-ALH is an effective excipient for designing sustained release drug delivery systems targeting the small intestine and colon.